ArticleCancer immunology, immunotherapy : CII2012

IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells.

Ute E Burkhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.